AZN
Ticker
AstraZeneca
Company
Biopharma
Industry
Healthcare
Sector
+
2009
+
2010
+
2011
+
2012
+
2013
+
2014
+
2015
+
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
1.4%1.0%-16.7%-8.1%3.3%-6.9%-6.9%-2.3%-1.7%10.4%9.2%40.6%18.5%3.3%18.0% 13.5%
Revenue Growth QoQ
Gross Margin
82.4%80.8%82.1%80.7%79.5%78.0%81.2%82.1%80.8%77.7%79.8%80.1%66.8%72.1%82.0%81.1% 82.4%
EBITDA Margin
41.5%42.8%45.7%38.1%32.3%20.4%28.2%31.6%29.9%32.3%27.4%31.2%20.3%20.8%29.6%30.9% 33.3%
Operating Margin
35.2%34.5%38.1%29.1%14.4%8.0%16.7%21.3%16.4%15.3%12.0%19.4%2.8%8.5%17.9%18.5% 22.0%
Profit Margin
23.0%24.3%29.8%22.4%10.0%4.7%11.4%15.2%13.4%9.8%5.5%12.0%0.3%7.4%13.0%13.0% 16.2%
FCF / EBITDA
74.5%59.7%42.5%21.8%64.4%79.5%7.7%25.2%29.2%17.5%7.6%26.4%49.6%78.3%48.4%43.6% 49.4%